Site is loading…
Most trials don't fail because the science was wrong. They fail because a site took on more than it could run. Because a coordinator missed a signal. Because a sponsor picked a partner off a spreadsheet with nothing useful on it.
Clinical research is drowning in information and starving for clarity. Crixeo exists in that gap.
We study systems under pressure. People, incentives, and the decisions that change outcomes. Game theory, ancient logic, anticipatory intelligence. That method produces everything we do, which is why our work looks like three businesses and behaves like one.
We publish what the industry already knows privately.
Patients and families can search trials by condition and location, look up the site that would treat them, and read plain-language guides on consent, safety, and what participation actually involves.
Sponsors, CROs, and investigators get standardized profiles on research sites: trial volume, sponsor diversity, therapeutic breadth, accreditation context, patient experience. Signals that live scattered across registries and disclosures, pulled into one view.
That view includes a Trust Score.
A Trust Score is not a verdict. It is a number with its work shown, built from public records and documented operating history. It does not tell you who to trust. It tells you what the record says, so you are not guessing.
And we say plainly how we get paid, because most companies here won't. Research sites hire us to become more visible, more capable, and worth more.
We bring them patients through search, conversion systems, AI screening, and follow-up. We bring them sponsors through positioning, profile strength, and reputation work. We fix how they operate through workflow design, automation, and reporting. We train their teams inside interactive simulations built around the decisions that actually break trials, run before the stakes are real instead of after.
And we build them revenue that does not depend on the next contract. Most sites live and die on sponsor awards, which means a slow quarter is an existential quarter. We find the income already latent in the business, the patient base, the facility, the data, the staff capacity, and turn it into channels the site controls.
Then we help owners grow through valuation, financing, partnerships, and M&A.
The two sides need each other.
The public platform shows the landscape honestly. The advisory business helps sites earn a better place in it. A directory nobody can act on is trivia. Advice without a public standard is just opinion.
Crixeo is independent. Our roots run back to an arts and culture enterprise funded by the William Wrigley Jr. fortune, which is where the habit of taking complicated systems apart came from, and we never lost it.
Find a trial. Find a site. Build a stronger research business.